US7388002B2
(en)
*
|
2001-11-14 |
2008-06-17 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
ES2563952T3
(es)
*
|
2004-03-26 |
2016-03-16 |
Sumitomo Dainippon Pharma Co., Ltd. |
Compuesto de 8-oxoadenina 9-sustituido
|
US7625881B2
(en)
*
|
2005-06-16 |
2009-12-01 |
Gilead Palo Alto, Inc. |
Prodrugs of A2B adenosine receptor antagonists
|
CA2620182A1
(en)
|
2005-08-22 |
2007-03-01 |
Dennis A. Carson |
Tlr agonists
|
TW200801003A
(en)
*
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
WO2007034817A1
(ja)
*
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
EP2700638A1
(en)
*
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purine analogs
|
JP2009542645A
(ja)
*
|
2006-07-05 |
2009-12-03 |
アストラゼネカ・アクチエボラーグ |
Tlr7のモジュレーターとして作用する8−オキソアデニン誘導体
|
PL2038290T3
(pl)
*
|
2006-07-07 |
2014-03-31 |
Gilead Sciences Inc |
Modulatory receptora Toll-podobnego 7
|
TW200831105A
(en)
*
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
SI2510946T1
(sl)
|
2007-02-07 |
2015-12-31 |
The Regents Of The University Of California |
Konjugati sintetičnih agonistov TLR in njihove uporabe
|
ATE490249T1
(de)
*
|
2007-02-19 |
2010-12-15 |
Glaxosmithkline Llc |
Purinderivate als immunmodulatoren
|
US8067413B2
(en)
*
|
2007-03-19 |
2011-11-29 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
|
ES2373616T3
(es)
*
|
2007-03-19 |
2012-02-07 |
Astrazeneca Ab |
Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
|
JPWO2008114819A1
(ja)
*
|
2007-03-20 |
2010-07-08 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
TW200902018A
(en)
*
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
MX2009011802A
(es)
*
|
2007-05-08 |
2009-11-18 |
Astrazeneca Ab |
Imidazoquinolinas con propiedades inmunomoduladoras.
|
EA024359B1
(ru)
*
|
2007-06-29 |
2016-09-30 |
Джилид Сайэнс, Инк. |
Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
|
PE20091156A1
(es)
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
CA2711769A1
(en)
|
2008-01-17 |
2009-07-23 |
Dainippon Sumitomo Pharma Co. Ltd. |
Method for preparing adenine compound
|
WO2009091031A1
(ja)
*
|
2008-01-17 |
2009-07-23 |
Dainippon Sumitomo Pharma Co., Ltd. |
アデニン化合物の製造方法
|
EP2259788A4
(en)
*
|
2008-02-07 |
2011-03-16 |
Univ California |
TREATMENT OF BLADDER DISEASES WITH A TLR7 ACTIVATOR
|
TWI444384B
(zh)
*
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
JP5600104B2
(ja)
*
|
2008-08-01 |
2014-10-01 |
ベンティアールエックス ファーマシューティカルズ, インコーポレイテッド |
Toll様受容体アゴニスト処方物およびその使用
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
ES2545275T3
(es)
|
2008-11-06 |
2015-09-09 |
Ventirx Pharmaceuticals, Inc. |
Métodos de síntesis de derivados de benzazepinas
|
US20100136097A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
US20100136094A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
US20100137844A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Delivery devices for modulating inflammation
|
US20100135983A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Anti-inflammatory compositions and methods
|
US20100136096A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
US20100137246A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Anti-inflammatory compositions and methods
|
US20100136095A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
CN102272134B
(zh)
*
|
2008-12-09 |
2013-10-16 |
吉里德科学公司 |
Toll样受体调节剂
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
BRPI1008383A2
(pt)
*
|
2009-02-11 |
2016-02-23 |
Univ California |
composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
|
AR075584A1
(es)
*
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
TW201105323A
(en)
*
|
2009-06-23 |
2011-02-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
TW201113279A
(en)
*
|
2009-06-23 |
2011-04-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
UY32715A
(es)
*
|
2009-06-23 |
2011-01-31 |
Gilead Sciences Inc |
Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
|
TR201909600T4
(tr)
*
|
2009-08-07 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Lipide edilmiş oksoadenin türevleri.
|
ES2620629T3
(es)
|
2009-08-18 |
2017-06-29 |
Ventirx Pharmaceuticals, Inc. |
Benzoazepinas sustituidas como moduladores del receptor tipo Toll
|
HUE031797T2
(en)
|
2009-08-18 |
2017-08-28 |
Ventirx Pharmaceuticals Inc |
Substituted benzoazepines as Toll-like receptor modulators
|
NZ598654A
(en)
|
2009-09-02 |
2014-05-30 |
Novartis Ag |
Immunogenic compositions including tlr activity modulators
|
PT2491035T
(pt)
*
|
2009-10-22 |
2017-10-30 |
Gilead Sciences Inc |
Derivados de purina ou deazapurina úteis para o tratamento de (entre outros) infeções virais
|
EP2507237A1
(en)
*
|
2009-12-03 |
2012-10-10 |
Dainippon Sumitomo Pharma Co., Ltd. |
Imidazoquinolines which act via toll - like receptors (tlr)
|
US20110150836A1
(en)
*
|
2009-12-22 |
2011-06-23 |
Gilead Sciences, Inc. |
Methods of treating hbv and hcv infection
|
JP6026405B2
(ja)
|
2010-04-30 |
2016-11-16 |
テロルメディクス エセアー |
リン脂質薬物類似体
|
CN103118682A
(zh)
*
|
2010-04-30 |
2013-05-22 |
加利福尼亚大学校务委员会 |
合成tlr7激动剂的磷脂缀合物的用途
|
US9050319B2
(en)
|
2010-04-30 |
2015-06-09 |
Telormedix, Sa |
Phospholipid drug analogs
|
US20120177681A1
(en)
|
2010-09-01 |
2012-07-12 |
Manmohan Singh |
Formulation of immunopotentiators
|
AU2011305652B2
(en)
|
2010-09-22 |
2016-10-20 |
Janssen Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
CN103370317B
(zh)
|
2010-12-16 |
2015-10-07 |
阿斯利康(瑞典)有限公司 |
可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
|
DK2651943T3
(en)
|
2010-12-17 |
2017-06-06 |
Sumitomo Dainippon Pharma Co Ltd |
purine derivatives
|
TW201306841A
(zh)
*
|
2010-12-20 |
2013-02-16 |
Gilead Sciences Inc |
治療c型肝炎病毒(hcv)之方法
|
CN103533954B
(zh)
|
2011-03-02 |
2015-09-09 |
诺华股份有限公司 |
含较低剂量的抗原和/或佐剂的联合疫苗
|
WO2013014052A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxosmithkline Llc |
Composition
|
CA2847204A1
(en)
|
2011-09-01 |
2013-03-07 |
Novartis Ag |
Adjuvanted formulations of staphylococcus aureus antigens
|
MX354958B
(es)
|
2011-09-16 |
2018-03-27 |
Gilead Pharmasset Llc |
Metodos para el tratamiento de vhc.
|
BR112014011340A2
(pt)
*
|
2011-10-07 |
2017-06-13 |
Gilead Sciences Inc |
métodos para a preparação de análogos de nucleotídeos antivirais
|
ES2734495T3
(es)
|
2011-12-22 |
2019-12-10 |
Geron Corp |
Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros
|
US20150030630A1
(en)
|
2012-03-07 |
2015-01-29 |
Novartis Ag |
Adjuvanted formulations of rabies virus immunogens
|
WO2013131983A1
(en)
|
2012-03-07 |
2013-09-12 |
Novartis Ag |
Adjuvanted formulations of streptococcus pneumoniae antigens
|
WO2013132041A2
(en)
|
2012-03-08 |
2013-09-12 |
Novartis Ag |
Adjuvanted formulations of booster vaccines
|
EP2659907A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
EP2659906A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
EP2659908A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
US9555036B2
(en)
|
2012-08-24 |
2017-01-31 |
Glaxosmithkline Llc |
Pyrazolopyrimidine compounds
|
CN103665043B
(zh)
*
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
CA2882619A1
(en)
|
2012-09-06 |
2014-03-13 |
Novartis Ag |
Combination vaccines with serogroup b meningococcus and d/t/p
|
JP6122960B2
(ja)
*
|
2012-10-08 |
2017-04-26 |
ダウ グローバル テクノロジーズ エルエルシー |
難燃性ポリウレタンフォーム用の有機リン化合物
|
MX2015004652A
(es)
|
2012-10-12 |
2015-08-05 |
Glaxosmithkline Biolog Sa |
Antigenos de pertusis acelulares no entrelazados para uso en vacunas de combinacion.
|
TWI485145B
(zh)
|
2012-10-26 |
2015-05-21 |
Ind Tech Res Inst |
P型有機半導體材料與光電元件
|
EA028480B1
(ru)
|
2012-11-20 |
2017-11-30 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Новые соединения
|
CN104780924B
(zh)
|
2012-11-20 |
2016-09-14 |
葛兰素史克有限责任公司 |
干扰素诱导剂化合物
|
KR20150085081A
(ko)
|
2012-11-20 |
2015-07-22 |
글락소스미스클라인 엘엘씨 |
신규 화합물
|
EP2950786B1
(en)
|
2013-01-31 |
2019-11-27 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
TR201807340T4
(tr)
|
2013-02-01 |
2018-06-21 |
Glaxosmithkline Biologicals Sa |
Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
|
MX2015015428A
(es)
|
2013-05-10 |
2016-07-18 |
Novartis Ag |
Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
|
CN104804042B
(zh)
*
|
2014-01-24 |
2018-01-19 |
齐鲁制药有限公司 |
核苷酸膦酸酯类化合物、其药物组合物、制备方法及用途
|
EP3639850A1
(en)
|
2014-03-26 |
2020-04-22 |
GlaxoSmithKline Biologicals S.A. |
Mutant staphylococcal antigens
|
WO2015197006A1
(zh)
*
|
2014-06-25 |
2015-12-30 |
四川海思科制药有限公司 |
一种取代的氨基酸硫酯类化合物、其组合物及应用
|
KR20190104438A
(ko)
|
2014-07-11 |
2019-09-09 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료를 위한 톨-유사 수용체의 조정제
|
EA201790369A1
(ru)
|
2014-09-16 |
2017-10-31 |
Джилид Сайэнс, Инк. |
Твердые формы модулятора толл-подобного рецептора
|
CA2969587A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Centre National De La Recherche Scientifique (Cnrs) |
Compounds for treating cystic fibrosis
|
EP3939985B1
(en)
|
2014-12-26 |
2024-05-08 |
Emory University |
Pharmaceutical compositions comprising n4-hydroxycytidine derivatives for the treatment or prevention of influenza or coronavirus infections
|
CA2984991A1
(en)
|
2015-05-04 |
2016-11-10 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
EP3302536A1
(en)
|
2015-06-03 |
2018-04-11 |
Affiris AG |
Il-23-p19 vaccines
|
WO2017005851A1
(en)
|
2015-07-07 |
2017-01-12 |
Affiris Ag |
Vaccines for the treatment and prevention of ige mediated diseases
|
MY192607A
(en)
*
|
2015-08-10 |
2022-08-29 |
Merck Sharp & Dohme |
Antiviral beta-amino acid ester phosphodiamide compounds
|
EP3386512B1
(en)
*
|
2015-12-10 |
2023-11-22 |
Merck Sharp & Dohme LLC |
Antiviral phosphodiamide prodrugs of tenofovir
|
EP3390413B1
(en)
*
|
2015-12-15 |
2020-08-19 |
Merck Sharp & Dohme Corp. |
Antiviral oxime phosphoramide compounds
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
KR20210118240A
(ko)
|
2016-10-14 |
2021-09-29 |
프리시젼 바이오사이언시스 인코포레이티드 |
B형 간염 바이러스 게놈 내의 인식 서열에 대해 특이적인 조작된 메가뉴클레아제
|
US10736908B2
(en)
|
2016-10-26 |
2020-08-11 |
Merck Sharp & Dohme Corp. |
Antiviral aryl-amide phosphodiamide compounds
|
TW201829412A
(zh)
|
2016-12-22 |
2018-08-16 |
美商默沙東藥廠 |
抗病毒之替諾福韋(tenofovir)之脂系酯前藥
|
WO2018118826A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antiviral benzyl-amine phosphodiamide compounds
|
EP3560943A4
(en)
*
|
2016-12-23 |
2020-09-02 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
NUCLEOSIDIC PHOSPHATE COMPOUND, PROCESS FOR PREPARATION AND USE
|
CN108948016B
(zh)
*
|
2017-05-19 |
2021-02-26 |
江苏恒瑞医药股份有限公司 |
嘌呤酮类衍生物、其制备方法及其在医药上的应用
|
JP2021035910A
(ja)
*
|
2017-11-01 |
2021-03-04 |
大日本住友製薬株式会社 |
置換プリン化合物
|
KR102626210B1
(ko)
|
2017-12-07 |
2024-01-18 |
에모리 유니버시티 |
N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도
|
JP7098748B2
(ja)
|
2017-12-20 |
2022-07-11 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
Stingアダプタータンパク質を活性化するホスホン酸結合を有する2’3’環状ジヌクレオチド
|
KR102492187B1
(ko)
|
2017-12-20 |
2023-01-27 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
Sting 어댑터 단백질을 활성화하는 포스포네이트 결합을 가진 3'3' 사이클릭 다이뉴클레오티드
|
JP7050165B2
(ja)
|
2018-02-26 |
2022-04-07 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hbv複製阻害剤としての置換ピロリジン化合物
|
WO2019195181A1
(en)
|
2018-04-05 |
2019-10-10 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis b virus protein x
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
CN111989335B
(zh)
|
2018-06-12 |
2023-06-13 |
四川科伦博泰生物医药股份有限公司 |
膦酰胺酯化合物及其盐和相关晶体形式、制备方法和用途
|
GB201811169D0
(en)
|
2018-07-06 |
2018-08-29 |
Kancera Ab |
New compounds
|
US11826375B2
(en)
|
2018-07-19 |
2023-11-28 |
Merck Sharp & Dohme Llc |
Phosphinic amide prodrugs of tenofovir
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
FI3873903T3
(fi)
|
2018-10-31 |
2024-03-26 |
Gilead Sciences Inc |
Substituoituja 6-azabentsiimidatsoliyhdisteitä HPK1-inhibiittoreina
|
CA3116347A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
CN113543851A
(zh)
|
2019-03-07 |
2021-10-22 |
捷克共和国有机化学与生物化学研究所 |
2’3’-环二核苷酸及其前药
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
AU2020231115A1
(en)
|
2019-03-07 |
2021-08-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
SI3952995T1
(sl)
|
2019-04-12 |
2023-12-29 |
Riboscience Llc |
Biciklični heteroarilni derivati kot zaviralci ektonukleotid pirofosfataze fosfodiesteraze 1
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TWI826690B
(zh)
|
2019-05-23 |
2023-12-21 |
美商基利科學股份有限公司 |
經取代之烯吲哚酮化物及其用途
|
CN114245807A
(zh)
|
2019-06-25 |
2022-03-25 |
吉利德科学公司 |
Flt3l-fc融合蛋白和使用方法
|
WO2021034804A1
(en)
|
2019-08-19 |
2021-02-25 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
CR20220129A
(es)
|
2019-09-30 |
2022-05-06 |
Gilead Sciences Inc |
Vacunas para vhb y métodos de tratamiento de vhb
|
EP4069729A1
(en)
|
2019-12-06 |
2022-10-12 |
Precision BioSciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
KR20220156884A
(ko)
|
2020-03-20 |
2022-11-28 |
길리애드 사이언시즈, 인코포레이티드 |
4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법
|
US11691963B2
(en)
|
2020-05-06 |
2023-07-04 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
|
CN111643661A
(zh)
*
|
2020-06-08 |
2020-09-11 |
王竹林 |
新型免疫佐剂、化合物及其应用
|
IL299980A
(en)
|
2020-08-07 |
2023-03-01 |
Gilead Sciences Inc |
Preparations of phosphonamide nucleotide analogues and their medicinal use
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
EP4267574A1
(en)
|
2020-12-23 |
2023-11-01 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
CA3217107A1
(en)
|
2021-05-13 |
2022-11-17 |
Daniel J. CLOUTIER |
Combination of a tlr8 modulating compound and anti-hbv sirna therapeutics
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
EP4359411A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CN117480155A
(zh)
|
2021-06-23 |
2024-01-30 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
AU2022299051A1
(en)
|
2021-06-23 |
2023-12-07 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
US11970494B2
(en)
|
2021-11-09 |
2024-04-30 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
|
TW202412816A
(zh)
*
|
2022-06-10 |
2024-04-01 |
美商弗沃德醫療公司 |
TNF—α活性調節劑
|
WO2024105159A1
(en)
*
|
2022-11-16 |
2024-05-23 |
University Of Zurich |
Ligands of the m6a-rna readers
|